Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05449418 · ClinicalTrials.gov registry record · NA

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities

A NA study of COVID-19, sponsored by Kaiser Permanente.

Active
Registry status
NA
Development phase
988
Enrollment target
2
Study locations

NCT05449418 is a NA study of COVID-19 that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 988 participants, below the 55,210-participant average among 203 other COVID-19 trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05449418, a NA study of COVID-19, is active but no longer recruiting, sponsored by Kaiser Permanente.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
988 participants
Enrollment target
2
Study locations

Study Summary

The ENSPIRE study is a cluster-randomized comparative effectiveness trial being conducted within long-term care and residential facilities that will test a communication and engagement strategy for increasing COVID-19 booster vaccination rates against an enhanced usual care comparator (Centers for Disease Control and Prevention or other national organization vaccine education and communication materials) among facility staff. The communication and engagement strategy being tested includes (1) the development of materials co-designed with and tailored to facility staff whose primary language is a language other than English or who are from certain cultural affinity groups and (2) the distribution of the developed materials by members of the language/cultural affinity groups with peer advocacy activities (full intervention). The study is being conducted in Washington state and Georgia. Long-term care/residential facilities will be asked to furnish their staff booster rate at 4 timepoints: pre-intervention, and one month (timepoint 1), 3 months (timepoint 2), and 6 months (timepoint 3) post-intervention. Staff at participating long-term care facilities will be invited to complete three online surveys at 3 timepoints: pre-intervention, 3 months post-intervention and 6 months post-intervention. Long-term care facilities will be randomized to a trial arm following the pre-intervention data collection.

Conditions Studied

Interventions

  • OTHER Enhanced Usual Care
  • BEHAVIORAL Full Intervention

Study Locations (2)

Georgia

  • Kaiser Permanente Georgia Center for Research and Evaluation - Atlanta

Washington

  • Kaiser Permanente Washington Health Research Institute - Seattle

Trial Details

FieldValue
Enrollment Target 988 participants
Start Date 2021-08-01
Est. Completion 2026-02-28
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT05449418

The ClinicalTrials.gov registry entry for NCT05449418 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 988 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,210-participant average among 203 other COVID-19 trials with a reported enrollment target (98% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT05449418 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Washington.

Frequently Asked Questions

What is clinical trial NCT05449418 about?

NCT05449418 is a clinical study titled "Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities". The ENSPIRE study is a cluster-randomized comparative effectiveness trial being conducted within long-term care and residential facilities that will test a communication and engagement strategy for increasing COVID-19 booster vaccination rates against an enhanced usual care comparator (Centers for D...

What is the current status of trial NCT05449418?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 988 participants. The study started on 2021-08-01. Estimated completion is 2026-02-28.

What conditions does trial NCT05449418 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT05449418?

The interventions under investigation include: Enhanced Usual Care (OTHER), Full Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05449418?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05449418 being conducted?

This trial has 2 study locations across Georgia, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.